Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APEDOC: Peripheral Nerve Blocks for Post-stroke Central Pain
NCT06446960Phase 3Completed
- Sponsor
- Inserm
- Start
- Feb 2024
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lidocaine, levobupivacaine in central poststroke pain (CPSP), sponsored by Inserm. Started Feb 2024; status: completed.
02
Drugs
lidocainelevobupivacaine
03
Conditions
central poststroke pain (CPSP)
Beyond the preview
Go deeper on NCT06446960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06446960.